Metformin: Difference between revisions

From The School of Biomedical Sciences Wiki
Jump to navigation Jump to search
Nnjm2 (talk | contribs)
No edit summary
mNo edit summary
 
(2 intermediate revisions by 2 users not shown)
Line 1: Line 1:
Metformin is a drug used primarily to treat [[Diabetes|type II diabetes]].<br>  
Metformin is an oral drug used primarily to treat [[Diabetes|type II diabetes]]. It can be used in combination with other drugs, and cannot treat type 1 diabetes. The derivative of Metformin is a plant called Galega officinalis, which is a French lilac. In medieval Europe, this plant&nbsp;was thought to have had herbal benefits, containing guanidine which showed hypoglycaemic properties. Unfortunately, it was too toxic to use as a treatment<references /><ref>Biochemical Journal Oct 16, 2015, 471 (3) 307-322</ref>.


Metformin works primarily by reducing hepatic [[Gluconeogenesis|gluconeogensis]], ultimately lowering blood/sugar levels and preventing [[Hyperglycemia|hyperglycemia]]<ref>Kirpichnikov D, McFarlane SI, Sowers JR. Metformin: an update. Ann Intern Med. 2002;137(1):25–33. PMID 12093242</ref>.<br>  
Metformin works primarily by reducing hepatic [[Gluconeogenesis|gluconeogensis]], ultimately lowering blood/sugar levels and preventing [[Hyperglycemia|hyperglycemia]]<ref>Kirpichnikov D, McFarlane SI, Sowers JR. Metformin: an update. Ann Intern Med. 2002;137(1):25–33. PMID 12093242</ref>.<br>


Metformin has also shown to inhibit the growth of pancreatic cancer by disrupting crosstalk between [[G-protein Coupled Receptor|G protein-coupled receptors]] and insulin receptor signalling systems in the [[Pancreas|pancreas]]<ref>Krisztina Kisfalvi, Guido Eibl, James Sinnett-Smith, and Enrique Rozengurt. Cancer Res August 15, 2009 69; 6539</ref>.
Metformin has also shown to inhibit the growth of pancreatic cancer by disrupting crosstalk between [[G-protein Coupled Receptor|G protein-coupled receptors]] and insulin receptor signalling systems in the [[Pancreas|pancreas]]<ref>Krisztina Kisfalvi, Guido Eibl, James Sinnett-Smith, and Enrique Rozengurt. Cancer Res August 15, 2009 69; 6539</ref>.  


<references />  
You should not take metformin if you have any history of liver or heart disease.
 
=== References  ===
 
<references />


<br>
<br>

Latest revision as of 15:28, 19 October 2015

Metformin is an oral drug used primarily to treat type II diabetes. It can be used in combination with other drugs, and cannot treat type 1 diabetes. The derivative of Metformin is a plant called Galega officinalis, which is a French lilac. In medieval Europe, this plant was thought to have had herbal benefits, containing guanidine which showed hypoglycaemic properties. Unfortunately, it was too toxic to use as a treatment[1].

Metformin works primarily by reducing hepatic gluconeogensis, ultimately lowering blood/sugar levels and preventing hyperglycemia[2].

Metformin has also shown to inhibit the growth of pancreatic cancer by disrupting crosstalk between G protein-coupled receptors and insulin receptor signalling systems in the pancreas[3].

You should not take metformin if you have any history of liver or heart disease.

References

  1. Biochemical Journal Oct 16, 2015, 471 (3) 307-322
  2. Kirpichnikov D, McFarlane SI, Sowers JR. Metformin: an update. Ann Intern Med. 2002;137(1):25–33. PMID 12093242
  3. Krisztina Kisfalvi, Guido Eibl, James Sinnett-Smith, and Enrique Rozengurt. Cancer Res August 15, 2009 69; 6539